(maintained) All guidance is based on Pre-TFRS 15 Core service revenue Mid-single digit growth Consolidated EBITDA margin Stable from last year Budgeted CAPEX Bt20-25bn Dividend policy Minimum 70% of
Company Limited (ECF-P) and ECF-P is the subsidiary held Consolidated Separate Amount Change Amount Change 2018 2017 Amount % 2018 2017 Amount % Revenue from sale – net 1,454.57 1,444.62 9.94 0.69% 1,443.43
Quarter 1 Consolidated Separate 3 months Change 3 months Change 2018 2017 Amount % 2018 2017 Amount % Revenue from sale – net 370.47 402.43 -31.97 -8% 364.64 398.50 -33.86 -8% Other incomes 11.06 7.31 3.75
Company Limited (“the Company”) would like to submit this Management Discussion and Analysis for the three - month period ended 31 March 2020 with details as follows: ( Since the consolidated financial
Baht 2.28 million or 3.83% from the corresponding period of the previous year as the following details below: 1. Revenue from sales and services increased Baht 36.13 million or 13.42% from the
consolidated reviewed the 3 rd quarter financial statements as of November 30, 2019 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized as
Government Saving Bank in Thailand. This is not only potentially decreases our funding costs but also stabilized company financial conditions. 2 Summary of Consolidated Financial Results 1. Operating Results
Government Saving Bank in Thailand. This is not only potentially decreases our funding costs but also stabilized company financial conditions. 2 Summary of Consolidated Financial Results 1. Operating Results
, the consolidated financial statements included the business of manufacturing and distribution of dialysis and medical equipment of a subsidiary during Q1 of 2018, with the sales revenue of 84.43 million
Result of Business Operations summarized as follows: 1. The Consolidated Financial Statements 1.1 Report and analysis of Business Operations Revenue Revenue from operations Revenue from operations for the